Correlation Between Pharvaris and Merck

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Merck Company, you can compare the effects of market volatilities on Pharvaris and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Merck.

Diversification Opportunities for Pharvaris and Merck

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Pharvaris and Merck is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of Pharvaris i.e., Pharvaris and Merck go up and down completely randomly.

Pair Corralation between Pharvaris and Merck

Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the Merck. But the stock apears to be less risky and, when comparing its historical volatility, Pharvaris BV is 1.22 times less risky than Merck. The stock trades about -0.26 of its potential returns per unit of risk. The Merck Company is currently generating about -0.19 of returns per unit of risk over similar time horizon. If you would invest  9,624  in Merck Company on November 22, 2024 and sell it today you would lose (935.00) from holding Merck Company or give up 9.72% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pharvaris BV  vs.  Merck Company

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Merck Company 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in March 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pharvaris and Merck Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and Merck

The main advantage of trading using opposite Pharvaris and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.
The idea behind Pharvaris BV and Merck Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas